|
| Status |
Public on Feb 16, 2021 |
| Title |
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
33602720, 35251031 |
| Submission date |
Feb 15, 2021 |
| Last update date |
Mar 10, 2022 |
| Contact name |
David Bargiela |
| E-mail(s) |
davidbargiela@gmail.com
|
| Organization name |
University of Cambridge
|
| Street address |
4, 7 Downing Pl
|
| City |
Cambridge |
| ZIP/Postal code |
CB2 3EL |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
|
| Samples (30)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE166756 |
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy [HIF1 Dataset] |
| GSE166757 |
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy [HIF2 Dataset] |
|
| Relations |
| BioProject |
PRJNA701908 |
Less...
More...